On January 26, 2025, China’s National Medical Products Administration (NMPA) released and implemented Several Provisions on Supporting Innovation in Cosmetic Ingredients. The Provisions outlines nine specific measures from multiple dimensions, including classification management, review and approval, and standard setting, with the aim of systematically supporting innovation in cosmetic ingredients and promoting high-quality development in the industry.

To ensure effective implementation of the Provisions, the NMPA also released an official policy interpretation, detailing the drafting purpose, formulation principles, key points, and technical requirements.